Shoulder Innovations, Inc.

NYSE:SI

Medical - Specialties

Healthcare
$20.65 -0.72%

-$0.13 today

Market cap
$432.04M
Beta
-1.07
P/E (TTM)
-8.4
EPS (TTM)
-$2.13
52W Low $10.92High $19.79

Volume 0.09M

Average 0.10M

SI Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Shoulder Innovations, Inc.NYSE: SI

Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026

Cash & equivalents rises 80.4% from a year ago

Cash & equivalents stood at $11.49M at the end of Q1 FY2026, up 80.4% from a year earlier and down 57.2% from the prior quarter.

Context

  • Cash & equivalents amounted to 7.2% of total assets at the end of Q1 FY2026, down 3.9 pp from a year earlier.
  • Cash & equivalents increased in 1 of the last 2 fiscal years.
  • FY2025 was the highest annual figure in the 3 fiscal years shown.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +80.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$11.49M-57.2% QoQ
Last fiscal yearDec 2025
$26.87M+338.9% YoY
Year agoMar 2025
$6.37M+80.4% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+80.4%——
1 year+338.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
26.87M USD
Year-over-year change
+338.9%
2-year CAGR
+107.6%

Cash & Equivalents vs competitors

How SI compares with its peers on the latest reported figures

  • SI's Mar 2026 cash & equivalents of $11.49M is the 10th highest of the 11 companies compared; the peer median is $33.02M.
  • Its year-over-year change of +80.4% is the 3rd highest of 11, against a peer median of +2.2%.
  • Cash & equivalents amounts to 7.2% of total assets for SI, versus a peer median of 21.8%.
SI Competitors Peer median
Cash & Equivalents for SI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
INGNInogen, Inc.Mar 2026$94.41M -20.6%-17.8%33.0%
AARDAardvark Therapeutics, Inc. Common StockMar 2026$62.44M +135.6%+44.6%63.3%
EPRXEupraxia Pharmaceuticals Inc.Mar 2026$58.69M +113.8%+48.2%40.2%
NNOXNano-X Imaging Ltd.Dec 2025$49.15M +25.1%+8.5%30.3%
ENTAEnanta Pharmaceuticals, Inc.Mar 2026$34.93M -42.0%-9.8%11.1%
ASMBAssembly Biosciences, Inc.Mar 2026$31.12M +32.9%+3.7%13.2%
OMOutset Medical, Inc.Mar 2026$30.56M -59.7%-21.8%12.3%
MDXHMDxHealth S.A.Jun 2026$19.21M -41.5%+23.3%14.5%
NAUTNautilus Biotechnology, Inc.Mar 2026$14.63M -56.0%-52.4%8.2%
SIShoulder Innovations, Inc.Mar 2026$11.49M +80.4%—7.2%
SNWVSANUWAVE Health, Inc.Mar 2026$10.78M +26.8%+118.1%29.1%
Peer median (excluding SI) $33.02M+2.2%+6.1%21.8%

Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents6.24M6.12M26.87M
Short-term Investments26.58M8.92M78K
Net Receivables4.69M5.12M8.27M
Inventory9.92M13.96M21.59M
Other Current Assets0573K3M
Total Current Assets47.85M35.13M157.17M
Property, Plant & Equipment (Net)5.75M7.56M12.64M
Goodwill000
Intangible Assets700K400K100K
Long-term Investments000
Tax Assets000
Other Non-current Assets000
Total Non-current Assets6.45M7.96M12.74M
Total Assets54.29M43.08M169.91M
Account Payables1.96M4.86M0
Short-term Debt43K47K62K
Tax Payables00(7.77M)
Deferred Revenue000
Other Current Liabilities228K554K(7.83M)
Total Current Liabilities4.28M7.65M(7.77M)
Long-term Debt14.35M14.66M14.96M
Deferred Tax Liabilities000
Deferred Revenue (Non-current)000
Other Non-current Liabilities75.33M75.45M0
Total Non-current Liabilities89.75M90.13M14.96M
Total Liabilities94.03M97.78M14.96M
Common Stock1K1K20.6B
Retained Earnings(41.42M)(57.04M)0
Accumulated OCI356K197K0
Other Stockholders Equity000
Minority Interest000
Total Equity(39.74M)(54.7M)154.95M
Total Debt14.47M14.73M15.02M
Net Debt8.23M8.61M(11.85M)

Shoulder Innovations, Inc.

NYSE:SI

Intrinsic Alpha fair value

Locked

Current Price

$20.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.